UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------------
FORM 8-K
Current Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 5, 1997
Lifecore Biomedical, Inc.
----------------------------------------------------
(Exact name of Registrant as specified in its charter)
Minnesota 41-0948334
- ------------------------------- ------------------
(State or other jurisdiction of (IRS Employer
incorporation or organization) Identification No.)
0-4136
----------------------
(Commission File Number)
3515 Lyman Boulevard
Chaska, Minnesota 55318
- ------------------------------- -----------------------
(Address of principal executive (Zip Code)
offices)
Registrant's telephone number, including area code: 612-368-4300
------------
ITEM 5. OTHER EVENTS
The press release included as Exhibit 21.1 is incorporated herein by
reference.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS PAGE NO.
(c) Exhibits
21.1 Press Release dated February 5, 1997 4
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
LIFECORE BIOMEDICAL, INC.
Dated: February 17, 1997 /s/ Dennis J. Allingham
-----------------------
Dennis J. Allingham
Vice President & Chief
Financial Officer
(Principal Financial Officer)
3